CHCHD2: a bi-organellar fulcrum of mitochondrial homeostasis and reproductive pathology

Mitochondrial dysfunction has been demonstrated with a role in pathologically driving various obstetric and gynecological (OB/GYN) diseases, but molecular mediators associating mitochondrial dysfunction with discrete pathologies have not been determined yet. CHCHD2, a bi-organellar protein called MNRR1 as well, integrates mitochondrial stress sensing with nuclear adaptive responses; nonetheless, its effect on reproductive disorder remains substantially paradoxical, which creates an important translational roadblock. Such ambiguity may not be arbitrary, instead, it may be associated with the unavailability of a uniform conceptual model in this field. In the present work, a new pathogenic framework called the 'Driver vs. Response' dichotomy was proposed and substantiated for resolving the above-mentioned paradox. According to our findings, the role of CHCHD2 conformed to the stark, context-dependent dichotomy: with its dysregulation manifested as the failed compensatory response associated with excess apoptosis in high-stress inflammatory states (such as preterm birth, preeclampsia). In comparison, under pro-survival pathological conditions (like ovarian cancer, endometriosis), its increased expression was the primary pathogenic driver, which suppressed apoptosis and conferred metabolic flexibility. The proposed framework identified CHCHD2 as the context-dependent mediator, which resolved an essential intellectual gap and exposed an important therapeutic dichotomy. Notably, the resolution of this challenge (protein inhibition within cancer is toxic and protein activation within preeclampsia is oncogenic) is an essential translational priority.